The activation of NF-κB signaling can occur through canonical or non-canonical pathways which have distinct roles in tumor progression; moreover, cancer cells have been shown to produce different proinflammatory and proangiogenic substances in direct response to NF-κB activity, as found in OC [51]. Here, NFKB1 is linked to cancer.